$34.34
-0.12-0.35%
Last update: Dec 15, 12:02 PM
Comments
Loading...
Lyell Immunopharma Earnings Estimates, EPS & Revenue | NASDAQ:LYEL | Benzinga
Lyell Immunopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 10
EPS Estimate
$-2.280
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$41.00K
Analyze the earnings history of Lyell Immunopharma using advanced sorting and filters.
Lyell Immunopharma (LYEL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $-2.13 | $-2.71 | 21.4 % |
| Q2 | 2025-08-12 | $-2.89 | $-2.90 | 0.34 % |
| Q1 | 2025-05-13 | $-3.60 | $-3.60 | 0.00 % |
| Q4 | 2025-03-11 | $-3.20 | $-2.60 | -23.1 % |
Lyell Immunopharma (LYEL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2021-11-12 | $2.76M | $2.30M | 19.8 % |
FAQ
When is Lyell Immunopharma (NASDAQ:LYEL) reporting earnings?
Lyell Immunopharma (LYEL) is scheduled to report earnings on March 10, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.
What were the latest earnings per share (EPS) for Lyell Immunopharma (NASDAQ:LYEL)?
The Actual EPS was $-2.13, which beat the estimate of $-2.71.
What were Lyell Immunopharma’s (NASDAQ:LYEL) revenues?
The Actual Revenue was $15K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
